Collagen microsphere serving as a cell carrier supports oligodendrocyte progenitor cell growth and differentiation for neurite myelination in vitro
© Yao et al.; licensee BioMed Central Ltd. 2013
Received: 21 June 2013
Accepted: 6 September 2013
Published: 9 September 2013
Microspheres fabricated from natural materials serve as a promising biodegradable and biocompatible carrier in a small volume for efficient cell delivery to the lesion of the injured neural tissue to generate biological functions. As the major component of extracellular matrix and due to its natural abundance within the body, collagen may be fabricated into microspheres and improve the ability of pre-seeded cells on the microspheres to encounter the hostile micro-environment in the lesion.
In this study, collagen microspheres were fabricated using the water-in-oil emulsion technique and cross-linked with 1-ethyl-3-(3-dimethylaminopropryl) carbodiimide. Oligodendrocyte progenitor cells isolated from postnatal day P1 to 2 rats were cultured and differentiated on the microspheres. The microspheres carrying the oligodendrocyte progenitor cells were co-cultured with dorsal root ganglions from 15-day-old rat embryos. The myelination formation was studied for the co-culture of oligodendrocyte progenitor cells and dorsal root ganglions.
We showed that the viability of oligodendrocyte progenitor cells, B104 cells and PC12 cells grown on microspheres was not significantly different with those in cell culture plates. Oligodendrocyte progenitor cells differentiated into oligodendrocytes on collagen microspheres. The oligodendrocytes grown on microspheres extended processes that wrapped the axons of dorsal root ganglion neurons and the formation of myelin sheath was observed in the co-culture.
This study demonstrates the feasibility of collagen microspheres in further applications for the delivery of neural progenitor cells for neural regeneration.
KeywordsMicrosphere Oligodendrocyte Cell delivery Co-culture Neural regeneration Dorsal root ganglion
Oligodendrocytes (OLs) undergo both necrosis and apoptosis shortly after spinal cord injury (SCI). Loss of OLs causes demyelination and thereby impairs axon function and survival [1–3]. In response to demyelination, the oligodendrocyte progenitor cells (OPCs), which produce the proteoglycan NG2 and express the platelet-derived growth factor-α receptor on the cell membrane, are recruited from gray and white matter and migrate to the demyelinated site . Direct evidence showed that OPCs will replace mature OLs after SCI and differentiate into OLs that eventually myelinate the axon . Axon remyelination after SCI typically begins around two weeks post-injury and the endogenous oligogenic response is insufficient against OL loss and demyelination post-SCI. Transplantation of OPCs is potentially an efficient approach to remyelinate regenerating axons and to recover the spinal cord function after injury [6, 7]. However, the microenvironment that the transplanted cells will encounter is the major concern in the process. Previous study showed that very few neural stem cells (NSCs) survive if directly transplanted to the site of damage . Biomaterial scaffold delivery of the stem cells for the treatment of injured spinal cord improved the survival of the transplanted cells [9, 10].
Micro- and nano-scale carriers fabricated from various natural and synthetic polymers have shown significant potential in biomedical and pharmaceutical applications. To encapsulate biomolecules in the particles to be delivered to the target tissues, the particles are able to generate a significant biological effect through a small volume [11–14]. Cell delivery and transplantation to the targeting tissue is an alternative application of the particles for the delivery of biomolecules. The investigation of microspheres for stem cell growth was reported in previous studies, which demonstrated a great potential of microspheres in stem cell delivery for tissue regeneration [15–17]. However, the feasibility of microspheres for neural progenitor cell growth for the repair of central nervous system has not been studied. Microspheres may provide the neural progenitor cells pre-seeded on the microspheres an optimal condition for the cells to adapt to the hostile environment in the lesion. The investigation of the growth, differentiation and ability for myelinating neurites of oligodendrocyte progenitor cells on microspheres will provide valuable information for its application in in vivo neural regeneration studies.
Collagen is the major component of extra-cellular matrix. Due to its natural abundance within the animal body, and its biodegradability and biocompatibility, collagen has been fabricated into microspheres and investigated for gene, growth factors and stem cell delivery [17–19]. Microspheres fabricated from collagen may work as efficient carriers for oligodendrocyte progenitor cell proliferation and differentiation, and can be potentially used to deliver OPCs to myelinate regenerating spinal axons of the injured spinal cord. In this study, we will investigate the growth and differentiation of OPCs on collagen microspheres and study myelination of the axons of dorsal root ganglion (DRG) neurons by OPCs carried by collagen microspheres in vitro. This study will provide us with important information for the further study of repairing the injured spinal cord using collagen microspheres delivering OPCs in the animal model.
Collagen microsphere fabrication
The collagen microspheres were fabricated as reported . In brief, Type I collagen (extracted from bovine Achilles tendon) solution (5 mg/ml) emulsified in liquid paraffin oil (Sigma-Aldrich, St. Louis, MO, USA) containing surfactant (Span 20, Sigma-Aldrich) (0.3% (v/v)) and stirred using a ceramic-top stirring plate (Fisher Scientific, Pittsburg, PA, USA) for five minutes. 1-ethyl-3-(3-dimethylaminopropryl) carbodiimide (EDC) (Sigma-Aldrich) (50% in water (v/v)) was added to the emulsified mixture, and was stirred for 1 h to form collagen microspheres. Ethanol (50% (v/v) in water) was then added into the mixture and stirred for five minutes to separate the collagen microspheres from the oil phase. The mixture was then centrifuged at 3,500 rpm for five minutes. This step was repeated three times to remove the supernatant. The collagen microspheres were washed with sterile phosphate-buffered saline (PBS) and centrifuged again (3,500 rpm five minutes) to remove the supernatant. Sterile PBS was added to the centrifuge tube to re-suspend the microspheres and the tube with the microsphere suspension was stored at 4°C before the cells were seeded. In the studies of cell viability assay and the co-culture of microspheres delivered OPCs and DRGs, 20% of microspheres generated by 1 ml collagen solution were placed in each well of a 48-well plate. The microspheres fully covered the bottom of the well and cells were seeded on top of the microspheres. To study the OPCs’ growth and differentiation on collagen microspheres with immunocytochemistry, 5% of the microspheres generated by 1 ml collagen solution were placed in each well of a 48-well plate. The immunolabeled cells on microspheres and on a cell culture plate can be easily visualized with the low density of the microspheres in the cell culture wells.
OPCs isolation and culture
Procedures used in animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) and completed at the Wichita State University, Wichita, KS, USA. OPC cultures were established as reported previously . In brief, postnatal day P1 to 2 rats were sacrificed and cerebral cortexes were isolated from the brain. The cortex tissues were each triturated gently and sequentially twice through needles with a 1-cc syringe. The tissue suspension was passed through a 70 mm nylon cell strainer (BD Falcon™, Durham, NC, USA) which was placed on a 50 ml conical tube and the flow-through was collected. The isolated cells were cultured for about seven days. The OPCs were then isolated from the mixed cell culture layer by mechanically shaking the cell culture flasks. The collected OPCs were cultured in cell culture dishes coated with Poly-D,L-ornithine (5 mg/ml in PBS, Sigma-Aldrich). The OPCs were fed with OPC growth medium containing DMEM (Life Technologies™, Grand Island, NY, USA), Sato media (DMEM, 100 μg/ml transferrin, 100 μg/ml BSA, 0.2 μM progesterone, 16 μg/ml putrescine, 40 ng/ml sodium selenite (Sigma-Aldrich)), 1% penicillin-streptomycin, 2 mM L-glutamine (Life Technologies™), 5 μg/ml insulin, 10 nM D-biotin, 1 mM sodium pyruvate, 5 μg/ml N-acetyl cysteine (Sigma-Aldrich), Trace Elements B (1x, Mediatech, Inc., Manassas, VA, USA) and 10 ng/ml PDGF and 10 ng/ml bFGF (Peprotech, Rocky Hill, NJ, USA). Then the OPCs were passaged or grown on collagen microspheres.
Cell viability assays
The viability and proliferation of OPCs, B104 cells and PC12 cells, which were seeded on collagen microspheres, were studied by monitoring their metabolic activity using alamarBlue assay (Pierce Biotechnology, Rockford, IL, USA). To perform the alamarBlue assay, the sterile PBS containing collagen microspheres was centrifuged and the microspheres were resuspended in the cell culture medium. The collagen microspheres were placed into the 48-well plates and the bottom of the cell culture wells were fully covered by the microspheres. After the microspheres were settled down at the bottom of the cell culture wells, the cells (15,000 cells/well) were added into the cell culture medium and the cells grew on the microspheres. In the control study, the cells (15,000 cells/well) were directly seeded in 48-well plates coated with poly-D,L-ornithine (5 mg/ml in PBS). After culturing for four days, the medium was gently removed from the wells and the cells were then incubated with culture medium containing 10% (v/v) alamarBlue reagent for two hours. Then the cell culture medium containing alamarBlue reagent was transferred to a 96-well plate (100 μl/well) and absorbance was measured at a wavelength of 570 nm and 600 nm in a microplate reader (Synergy Mx Monochromator-Based Multi-Mode Microplate Reader, Winooski, VT, USA). The cell viability of the 3T3 cells and PC12 cells growing on the collagen microspheres was analyzed by fluorescence-based LIVE/DEAD® assays (Life Technologies™). The Calcein and EthD-1 labeled cells were counted and quantified to show the rate of live cells on the collagen microspheres.
DRG isolation and culture
DRGs from 15-day-old Sprague Dawley rat embryos were isolated and cultured in the collagen-coated 24-well-plate wells . The whole DRGs were cultured in Neurobasal media supplemented with B27, 1% penicillin/streptomycine, 2 mM L-glutamine (Life Technologies™), 20 ng/ml 2.5S nerve growth factor (NGF, Alomone Labs, Jerusalem, Israel), 8.625 μg/ml uridine and 3.75 μg/ml of 5-fluoro-2- deoxyuridine (Sigma-Aldrich). The DRGs were cultured for 10 days before they were co-cultured with OPCs.
OPCs and DRG co-culture
OPCs (15,000 cells/well) were seeded on the collagen microspheres and cultured with OPCs growth medium for two days. The collagen microspheres with pre-seeded OPCs were then transferred into the wells with the growth of DRGs . In the control group, OPCs (15,000 cells/well) were added into the DRG culture wells. The co-culture of the DRG and OPCs were maintained for eight days in the DMEM with Sato media, 1% penicillin-streptomycin, 2 mM L-glutamine, 5 μg/ml insulin, 10 nM D-biotin, 1 mM sodium pyruvate, 5 μg/ml N-acetyl cysteine, Trace Elements B and Triiodothyronine (Sigma-Aldrich). Negative control was performed to treat the cultured DRG with the co-culture medium without adding OPCs in the cell culture.
OPCs and DRGs were fixed with 4% paraformaldehyde in PBS solution. The phenotype of the cultured OPCs was determined with anti-A2B5 antibody (a gift from Dr Qing Lu, University of Texas Southwestern Medical Center). The differentiated OPCs were labeled with anti-O4 antibody (a gift from Dr Qing Lu, University of Texas Southwestern Medical Center) and anti-Myelin Basic Protein (MBP) antibody (Millipore, Billerica, MA, USA). Dual labeling of DRG neuron axons and oligodendrocyte were performed to study the myelination of the DRG axons using anti-IIIβ-tubulin antibody (Millipore) and anti-MEB antibody, respectively. The images were taken using Zeiss Axio Observer microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY, USA).
Statistical analysis was conducted using a two-tailed Student’s t-test. A P-value of 0.05 was considered to be statistically significant. Data are expressed as means ± standard deviation.
Collagen microspheres supported the proliferation of the cells grown on the surface of the microspheres
The LIVE/DEAD® assay and alamarBlue assay were performed to analyze the cell viability of the cells grown on the collagen microspheres. The LIVE/DEAD® assay showed that most 3T3 cells that grew on the surface of collagen microspheres were live cells (Figure 1D-F). Further quantification showed that after being cultured for three days, the rate of live cells of 3T3 cells and PC12 cells was 91.5 ± 4.3% and 94.3 ± 2.9% (n = 3, mean ± SD), respectively, which is not significantly different from that of the cells that grew in cell culture dishes (Figure 1H). The alamarBlue assay showed that the reduction of alamarBlue reagent for the OPCs, B104 cells and PC12 cells grown on collagen microspheres was 27.9 ± 2.2%, 52.9 ± 1.6%, and 23.1 ± 6.2%, (n = 4, mean ± SD), respectively, which was not significantly different from that on cell culture plates (OPCs, 21.7 ± 5.5%; B104 cells, 56.1 ± 2.4%; PC12 cells, 19.5 ± 5.1%) (n = 4, mean ± SD) (Figure 1I).
Collagen microspheres support the differentiation of OPCs grown on the microspheres
OPCs seeded on collagen microspheres differentiated and formed myelin sheaths for neurites of the cultured DRG neurons
In this study, collagen microspheres were fabricated using the water-in-oil emulsion technique and cross-linked with EDC. We showed that the viability of oligodendrocyte progenitor cells, B104 cells and PC12 cells grown on collagen microspheres was not significantly different from that in the cell culture plates. We also showed that OPCs differentiated into oligodendrocytes on collagen microspheres. The OPCs were then grown on collagen microspheres and co-cultured with DRGs. We demonstrated that the oligodendrocytes grown on microspheres extended processes that wrapped the axons of DRGs and the myelin sheath formation for the neurites of DRG neurons was observed.
Microspheres fabricated from biocompatible materials provide a supportive environment for cell growth, while the cells growing on the microspheres can also modify the structure of the microspheres. Previous work showed that the ability of porous chitosan microspheres can support adipose-derived stem cell growth . When the spheres were incubated with adipose-derived stem cells (ADSCs), the spheres proliferated on the surface of the spheres, as well as infiltrated the pores to grow within the spheres as well. The cells growing on spheres maintained their metabolic activity and viability. Because of its biological and structural properties, type I collagen has been processed as an engineered scaffold for neural regeneration [23–25]. EDC cross-linked neural conduits were fabricated in previous studies and their biocompatibility was shown by growing dorsal root ganglion in the cross-linked collagen conduits . It was also demonstrated that the EDC cross-linked collagen conduits supported peripheral nerve regeneration after the implantation of neural conduits in the transected rat sciatic nerve . In this study, we showed the proliferation of OPCs, PC12 cells and B104 cells on collagen microspheres was not significantly different from that in cell culture plates. We observed that most collagen microspheres maintained round morphology after the OPCs were grown on the microspheres for three days. However, we found the morphology of the microspheres changed after the OPCs were cultured on the microspheres after eight days. Some round collagen microspheres changed to an irregular morphology. This suggests the OPCs can gradually re-organize the morphology of the collagen microspheres. In in vivo studies, it is likely that OPC-grown collagen microspheres will be transplanted into the wounded neural tissue after the OPCs are cultured on collagen microspheres for two to four days, as the OPCs can easily maintain their phenotype during the period in vitro. After two to four days’ culture, the microspheres should efficiently deliver the OPCs to the wounded neural tissue. The OPCs are expected to incorporate into the local tissue with the degradation of the collagen microspheres.
For the cell transplantation and therapy, stem cells delivered by the microspheres need to maintain their phenotype and their differentiation ability. We observed that OPCs showed the A2B5 marker in OPCs medium and differentiated into oligodendrocytes with differentiation medium when they were cultured on collagen microspheres. We found that the oligodendrocytes extended processes around the microspheres and established connection with other oligodendrocytes. This study suggests that collagen is a biocompatible material that can support OPC growth and differentiation. The cross-linking reagent EDC is not toxic to the OPCs. In this study, 15,000 cells were on microspheres of each well for viability assay and for co-culture with DRGs. The concern of significantly increasing the OPCs seeding density on microspheres is that OPCs cannot maintain the phenotype and differentiate into oligodendrocytes. The OPCs’ seeding density on microspheres for transplantation studies should be optimized in further in vivo studies. Different from the in vitro condition, after transplantation into the wounded neural tissue, OPCs may adhere to the surrounding tissue and grow and some of the OPCs may die off. The optimal OPCs’ density for transplantation should be higher compared with that for the current study.
Targeting the cell transplantation to the lesion and therapy, it is important to maintain the cell’s function in the process of cell encapsulation. In order to ensure this, the type of polymer used must fulfill appropriate mechanical durability, pore size, capsule consistency, degradation features and low immunogenicity . Therefore, natural polymers are strongly favored because they are usually biodegradable, nontoxic and non-immunogenic. Previous study showed that collagen type I gel can support the growth of neural stem/precursor cells (NSPCs) and the NSPCs could differentiate into neurons, astrocytes and oligodendrocytes in the collagen gel . In another study, OPCs were grown on coverslips coated with fibronectin, laminin or Matrigel and the results showed that these ECM components enhanced the biological properties of the OPCs compared with a non-ECM substrate . Potentially, collagen and fibronectin can be fabricated as hydrogel or microspheres for OPCs delivery to treat the injured spinal cord. Different from the hydrogel approach, which is particularly suitable to fill neural defect, microspheres could be delivered with PBS to a lesion without significant neural defect because the size of the microspheres is relatively small. Additionally, as the collagen or fibronectin is mechanically elastic, collagen- or fibronectin-based microspheres will create little damage to the healthy tissue after implantation. Previous studies showed that the degradation property of the collagen scaffolds can be modified by changing cross-linking reagent concentration. The degradation rate of the collagen microspheres can be regulated by modifying the level of the cross-linking reagent. The degradation of the microspheres will be determined by in vivo study. The degradation rate can be optimized by studying the microsphere degradation rate and cell survival in vivo. The optimal degradation rate is the maximal OPCs cell survival with the removal of the microspheres from the host tissue.
In this study we showed that collagen microspheres can support the growth and differentiation of OPCs that were seeded on the microspheres. Oligodendrocytes extended multiple processes that surrounded the collagen microspheres and wrapped the neurites of the DRGs. The formation of a myelin sheath was observed in the co-culture of DRGs and OPCs carried by collagen microspheres. This study demonstrates the potential of collagen microspheres in the applications of delivery and transplantation of neural stem cells for neural regeneration of in the central nervous system.
Adipose-derived stem cells
Bovine serum albumin
Dulbecco’s modified Eagle’s medium
Dorsal root ganglion
Institutional Animal Care and Use Committee
Myelin basic protein
Nerve growth factor
Neural stem cells
Neural stem/precursor cells
Oligodendrocyte progenitor cells
Phosphate buffered saline
Spinal cord injury.
This work was supported by the National Center for Research Resources (P20 RR016475) and the National Institute of General Medical Sciences (P20 GM103418) from the National Institutes of Health, and Award for Research/Creative Projects (ARCS), Wichita State University. We would like to thank Dr. Qing Lu for providing us the antibodies and technical support.
- Gledhill RF, Harrison BM, McDonald WI: Demyelination and remyelination after acute spinal cord compression. Exp Neurol. 1973, 38: 472-487. 10.1016/0014-4886(73)90169-6.View ArticlePubMed
- McTigue DM, Horner PJ, Stokes BT, Gage FH: Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci. 1998, 18: 5354-5365.PubMed
- Oluich LJ, Stratton JA, Xing YL, Ng SW, Cate HS, Sah P, Windels F, Kilpatrick TJ, Merson TD: Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J Neurosci. 2012, 32: 8317-8330. 10.1523/JNEUROSCI.1053-12.2012.View ArticlePubMed
- Almad A, Sahinkaya FR, McTigue DM: Oligodendrocyte fate after spinal cord injury. Neurotherapeutics. 2011, 8: 262-273. 10.1007/s13311-011-0033-5.PubMed CentralView ArticlePubMed
- Wang S, Sdrulla AD, DiSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA: Notch receptor activation inhibits oligodendrocyte differentiation. Neuron. 1998, 21: 63-75. 10.1016/S0896-6273(00)80515-2.View ArticlePubMed
- Jeffery ND, Crang AJ, O’leary MT, Hodge SJ, Blakemore WF: Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord. Eur J Neurosci. 1999, 11: 1508-1514. 10.1046/j.1460-9568.1999.00564.x.View ArticlePubMed
- Lee KH, Yoon DH, Park YG, Lee BH: Effects of glial transplantation on functional recovery following acute spinal cord injury. J Neurotrauma. 2005, 22: 575-589. 10.1089/neu.2005.22.575.View ArticlePubMed
- Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK: Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A. 2004, 101: 11839-11844. 10.1073/pnas.0404474101.PubMed CentralView ArticlePubMed
- Nomura H, Zahir T, Kim H, Katayama Y, Kulbatski I, Morshead CM, Shoichet MS, Tator CH: Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng Part A. 2008, 14: 649-665. 10.1089/tea.2007.0180.View ArticlePubMed
- Johnson PJ, Tatara A, McCreedy DA, Shiu A, Sakiyama-Elbert SE: Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter. 2010, 6: 5127-5137. 10.1039/c0sm00173b.PubMed CentralView ArticlePubMed
- Kim YT, Caldwell JM, Bellamkonda RV: Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury. Biomaterials. 2009, 30: 2582-2590. 10.1016/j.biomaterials.2008.12.077.PubMed CentralView ArticlePubMed
- Ranjan OP, Shavi GV, Nayak UY, Arumugam K, Averineni RK, Meka SR, Sureshwar P: Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Arch Pharm Res. 2011, 34: 1919-1929. 10.1007/s12272-011-1112-1.View ArticlePubMed
- Zhao Q, Han B, Wang Z, Gao C, Peng C, Shen J: Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle:doxorubicin loading and in vitro and in vivo studies. Nanomedicine. 2007, 3: 63-74. 10.1016/j.nano.2006.11.007.View ArticlePubMed
- Mathew ST, Devi SG, Prasanth VV, Vinod B: Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration. J Microencapsul. 2009, 26: 456-469.PubMed
- Yao R, Zhang R, Luan J, Lin F: Alginate and alginate/gelatin microspheres for human adipose-derived stem cell encapsulation and differentiation. Biofabrication. 2012, 4: 025007-10.1088/1758-5082/4/2/025007.View ArticlePubMed
- Natesan S, Baer DG, Walters TJ, Babu M, Christy RJ: Adipose-derived stem cell delivery into collagen gels using chitosan microspheres. Tissue Eng Part A. 2010, 16: 1369-1384. 10.1089/ten.tea.2009.0404.PubMed CentralView ArticlePubMed
- Chan BP, Hui TY, Wong MY, Yip KH, Chan GC: Mesenchymal stem cell-encapsulated collagen microspheres for bone tissue engineering. Tissue Eng Part C Methods. 2010, 16: 225-235.View ArticlePubMed
- Helary C, Browne S, Mathew A, Wang W, Pandit A: Transfection of macrophages by collagen hollow spheres loaded with polyplexes: a step towards modulating inflammation. Acta Biomater. 2012, 8: 4208-4214. 10.1016/j.actbio.2012.06.017.View ArticlePubMed
- Nagai N, Kumasaka N, Kawashima T, Kaji H, Nishizawa M, Abe T: Preparation and characterization of collagen microspheres for sustained release of VEGF. J Mater Sci Mater Med. 2010, 21: 1891-1898. 10.1007/s10856-010-4054-0.View ArticlePubMed
- Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR: Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc. 2007, 2: 1044-1051. 10.1038/nprot.2007.149.View ArticlePubMed
- Yao L, Billiar KL, Windebank AJ, Pandit A: Multichanneled collagen conduits for peripheral nerve regeneration: design, fabrication, and characterization. Tissue Eng Part C Methods. 2010, 16: 1585-1596.View ArticlePubMed
- O’Meara RW, Ryan SD, Colognato H, Kothary R: Derivation of enriched oligodendrocyte cultures and oligodendrocyte/neuron myelinating co-cultures from post-natal murine tissues. J Vis Exp. 2011, 54: 3324-PubMed
- Koutsopoulos S, Zhang S: Long-term three-dimensional neural tissue cultures in functionalized self-assembling peptide hydrogels, Matrigel and Collagen I. Acta Biomater. 2013, 9: 95162-95169.View Article
- Cao J, Xiao Z, Jin W, Chen B, Meng D, Ding W, Han S, Hou X, Zhu T, Yuan B, Wang J, Liang W, Dai J: Induction of rat facial nerve regeneration by functional collagen scaffolds. Biomaterials. 2013, 34: 1302-1310. 10.1016/j.biomaterials.2012.10.031.View ArticlePubMed
- Abou Neel EA, Bozec L, Knowles JC, Syed O, Mudera V, Day R, Hyun JK: Collagen - Emerging collagen based therapies hit the patient. Adv Drug Deliv Rev. 2013, 65: 429-456. 10.1016/j.addr.2012.08.010.View ArticlePubMed
- Yao L, de Ruiter GC, Wang H, Knight AM, Spinner RJ, Yaszemski MJ, Pandit A: Controlling dispersion of axonal regeneration using a multichannel collagen nerve conduit. Biomaterials. 2010, 31: 5789-5797. 10.1016/j.biomaterials.2010.03.081.View ArticlePubMed
- Prakash S, Soe-Lin H: Strategy for cell therapy: polymers for live cell encapsulation and delivery. Trends Biomater Artif Organs. 2004, 18: 24-35.
- Watanabe K, Nakamura M, Okano H, Toyama Y: Establishment of three-dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel. Restor Neurol Neurosci. 2007, 25: 109-117.PubMed
- Hu J, Deng L, Wang X, Xu XM: Effects of extracellular matrix molecules on the growth properties of oligodendrocyte progenitor cells in vitro. J Neurosci Res. 2009, 87: 2854-2862. 10.1002/jnr.22111.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.